Clinical Trials > Melanoma > SelPac

  • Information
  • Sites - Open
  • Map of Sites
SelPac

Title

A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
II Open University of Liverpool EUDRACT No: 2014-004437-22
ISRCTN No:
77

Purpose


Trial Lead Organisations


Official Title

A Randomised three-arm, open label, Phase II study of continuous Selumetinib versus continuous or interrupted Selumetinib in combination with weekly Paclitaxel in Metastatic Uveal Melanoma.


Trial Start Date

26/08/2015


References


Trial Coordinator

Louise Handley


Trial Coordinator Email Address

lhandley@liv.ac.uk


Trial Coordinator Contact No

0151 794 8935



UK: ENGLAND

  • , Addenbrooke's Hospital (Cambridge) (Pippa Corrie)
  • , Freeman Hospital (Newcastle) (Ruth Plummer)
  • , Mount Vernon Cancer Centre (Northwood) (Paul Nathan)
  • , Nottingham City Hospital (Poulam Patel)
  • , Queen Elizabeth Hospital (Birmingham) (Neil Steven)
  • , Royal Devon & Exeter Hospital (Andrew Goodman)
  • , Southampton General Hospital (Ioannis Karydis)
  • , The Christie (Manchester) (Paul Lorigan)
  • , The Royal Marsden Hospital (London) (James Larkin)
  • , Weston Park Hospital (Sheffield) (Sarah Danson)
  • Wirral, The Clatterbridge Cancer Centre (Wirral) (Joseph Sacco)

UK: SCOTLAND

  • , The Beatson West of Scotland Cancer Centre (Glasgow) (Jeff Evans)

UK: WALES

  • , Velindre Cancer Centre (Cardiff) (Satish Kumar)

Interactive Map

To find out more information about a hospital within your area click on the pin.

Login

Username:
Password:

Lost Username / Password?